GO:0001221 transcription coregulator binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0001221 transcription coregulator binding describes the molecular function of binding to a transcription coregulator, a protein that regulates transcription through protein-protein interactions rather than direct DNA binding.
• Coregulators bridge sequence-specific DNA-binding transcription factors and the basal transcription machinery, enabling context-dependent gene regulation.
• Integration of coregulator complexes with DNA-binding factor interactomes reveals combinatorial and cell-type-specific regulatory networks.
• Atypical coregulators such as Zincore can bind zinc finger transcription factors and control gene expression, expanding the known repertoire of coregulator interactions.
• Coregulator binding is central to nuclear receptor signaling, with coactivators and corepressors determining agonist versus antagonist outcomes.
• Dysregulated coregulator interactions contribute to cancer progression, including prostate cancer via the HSF1-DBC1 axis.
Description
Transcription coregulator binding (GO:0001221) is a molecular function that defines the physical interaction between a protein and a transcription coregulator. Coregulators are proteins that do not bind DNA directly but instead mediate protein-protein interactions between sequence-specific transcription factors and the basal transcription machinery, thereby modulating gene expression. This function is essential for converting DNA-binding signals into appropriate transcriptional outputs in development, homeostasis, and disease. Understanding transcription coregulator binding is therefore fundamental for researchers mapping gene regulatory networks and designing targeted interventions. Recent studies have systematically integrated transcription coregulator complexes with sequence-specific DNA-binding factor interactomes, revealing how combinatorial interactions shape cell-type-specific transcription programs. Atypical coregulators, such as Zincore, have been shown to bind zinc finger transcription factors and control gene expression, highlighting the diversity of proteins that can serve as coregulators. Moreover, gene regulation by convergent promoters and the Integrator complex illustrates how coregulator binding contributes to gene-specific transcription regulation. These findings underscore the importance of GO:0001221 in both basic and translational research.
transcription coregulator binding At A Glance
| GO ID | GO:0001221 |
|---|---|
| GO term | transcription coregulator binding |
| Ontology | molecular_function |
| Synonym | RNA polymerase II transcription cofactor binding; RNA polymerase II transcription coregulator binding; transcription cofactor binding |
| Major function | Binding to transcription coregulators to mediate protein-protein interactions between transcription factors and the basal transcription machinery |
| Definition source | QuickGO |
| Related processes | Transcription regulation, signal transduction, development, disease |
| Cellular context | Nucleus, chromatin, transcription factor complexes |
What Is GO:0001221?
According to the Gene Ontology, GO:0001221 transcription coregulator binding is the binding to a transcription coregulator, a protein involved in regulation of transcription via protein-protein interactions with transcription factors and other transcription regulatory proteins. Cofactors do not bind DNA directly, but rather mediate protein-protein interactions between regulatory transcription factors and the basal transcription machinery. Synonyms include RNA polymerase II transcription cofactor binding, RNA polymerase II transcription coregulator binding, and transcription cofactor binding.
Why Is transcription coregulator binding Important in Cell Biology?
Transcription coregulator binding is a central node in gene regulation because it determines how DNA-binding transcription factors communicate with the basal transcription machinery. Without coregulator binding, sequence-specific transcription factors cannot effectively activate or repress transcription. This function is critical for integrating signaling pathways, as exemplified by nuclear receptor coregulators that mediate responses to hormones and drugs. Dysregulation of coregulator interactions is implicated in cancer, metabolic disorders, and developmental abnormalities. Therefore, studying GO:0001221 provides mechanistic insights into normal physiology and disease, and informs the development of therapeutics targeting transcriptional networks.
• Coregulator binding enables combinatorial control of gene expression, allowing a limited number of transcription factors to generate diverse expression patterns.
• It is essential for nuclear receptor signaling, where coactivators and corepressors determine the transcriptional response to ligands.
• Atypical coregulators like Zincore expand the functional repertoire of transcription factor interactions.
• Coregulator binding is involved in gene regulation by convergent promoters and the Integrator complex, affecting gene-specific transcription.
• Dysregulated coregulator interactions drive cancer progression, including prostate cancer via the HSF1-DBC1 axis.
• Understanding coregulator binding aids in interpreting non-coding genetic variants that affect regulatory elements.
• It provides a basis for designing drugs that modulate protein-protein interactions in transcription.
• Coregulator binding is relevant to stem cell pluripotency and differentiation.
• It contributes to immune cell function and inflammatory responses.
• Studying coregulator binding can reveal mechanisms of resistance to endocrine therapies.
Molecular Mechanism of transcription coregulator binding
Recognition of transcription factors by coregulators
In simple terms: Coregulators recognize and bind to specific transcription factors.
Transcription coregulators contain interaction domains that recognize short linear motifs or folded domains on sequence-specific transcription factors. For example, Zincore binds zinc finger transcription factors to control gene expression. This recognition is highly specific and determines which genes are regulated. Integration of coregulator complexes with DNA-binding factor interactomes has revealed that coregulators can interact with multiple transcription factors, forming combinatorial networks.
Assembly of coregulator complexes
In simple terms: Multiple coregulators come together to form large complexes.
Coregulators often assemble into multi-subunit complexes that include chromatin-modifying enzymes, such as histone acetyltransferases and deacetylases. These complexes are recruited to DNA-bound transcription factors and modify chromatin to either facilitate or repress transcription. The Integrator complex is an example of a coregulator complex that regulates gene-specific transcription. The assembly of these complexes is dynamic and regulated by signaling pathways.
Bridging to the basal transcription machinery
In simple terms: Coregulators connect transcription factors to the general transcription machinery.
Once bound to transcription factors, coregulators mediate protein-protein interactions with the basal transcription machinery, including RNA polymerase II and general transcription factors. This bridging function is essential for initiating transcription. The definition of GO:0001221 explicitly states that cofactors do not bind DNA directly but mediate these interactions. This step is a key point of regulation and is targeted by many signaling pathways.
Regulation by post-translational modifications
In simple terms: Chemical modifications on coregulators can turn their activity on or off.
Coregulator binding and activity are regulated by post-translational modifications such as phosphorylation, acetylation, and ubiquitination. These modifications can alter the affinity of coregulators for transcription factors or change their interactions with other complex components. For instance, nuclear receptor coregulators are subject to regulation by phosphorylation, which affects their coactivator or corepressor function. Such modifications provide a layer of dynamic control over transcription coregulator binding.
Convergent promoters and bidirectional regulation
In simple terms: Coregulators can influence genes that are transcribed from shared promoter regions.
Coregulator binding also plays a role in gene regulation by convergent promoters, where two genes are transcribed from overlapping regions. Studies have shown that coregulators can differentially affect the expression of convergent genes. Molecular models of bidirectional promoter regulation suggest that coregulator interactions contribute to the coordination of divergent transcription. This adds another dimension to how coregulator binding shapes the transcriptome.
Key Genes Involved in GO:0001221 transcription coregulator binding
The following genes encode proteins that are known to bind transcription coregulators or act as coregulators themselves, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NCOA1 | Nuclear receptor coactivator 1 | Mediates coactivator binding to nuclear receptors; studied in hormone-dependent cancers |
| NCOA2 | Nuclear receptor coactivator 2 | Enhances transcription factor activity; implicated in leukemia and solid tumors |
| NCOR1 | Nuclear receptor corepressor 1 | Recruits histone deacetylases to repress transcription; linked to endocrine resistance |
| NCOR2 | Nuclear receptor corepressor 2 | Corepressor for nuclear receptors; involved in development and cancer |
| EP300 | E1A binding protein p300 | Histone acetyltransferase coactivator; interacts with many transcription factors |
| CREBBP | CREB binding protein | Coactivator with acetyltransferase activity; mutated in Rubinstein-Taybi syndrome |
| MED1 | Mediator complex subunit 1 | Component of Mediator complex bridging transcription factors and RNA polymerase II |
| Zincore | Atypical coregulator | Binds zinc finger transcription factors to control gene expression |
| HSF1 | Heat shock transcription factor 1 | Interacts with coregulators; drives metastatic transcriptional program in prostate cancer |
| DBC1 | Deleted in breast cancer 1 | Coregulator that interacts with HSF1; promotes prostate cancer progression |
| INTS11 | Integrator complex subunit 11 | Part of Integrator complex; regulates gene-specific transcription |
| CTR9 | Component of PAF1 complex | Coregulator associated with RNA polymerase II; involved in transcription elongation |
| LEO1 | Component of PAF1 complex | Coregulator that binds transcription factors; links to chromatin modification |
| WDR5 | WD repeat domain 5 | Coregulator in MLL complexes; binds transcription factors and histones |
| KMT2A | Lysine methyltransferase 2A | Histone methyltransferase coregulator; involved in leukemia |
| BRD4 | Bromodomain containing 4 | Binds acetylated histones and transcription factors; target in cancer |
| TRIM24 | Tripartite motif containing 24 | Coregulator for nuclear receptors; implicated in breast cancer |
How Is transcription coregulator binding Regulated?
Transcription coregulator binding is regulated at multiple levels. Post-translational modifications of coregulators, such as phosphorylation, acetylation, and ubiquitination, can alter their binding affinities and interactions. Signaling pathways, including nuclear receptor signaling, modulate coregulator recruitment by changing the conformation or modification state of transcription factors. Additionally, the availability of coregulators can be controlled by their expression levels, which are often tissue-specific. For example, the HSF1-DBC1 axis in prostate cancer demonstrates how coregulator interactions can be hijacked to drive a metastatic transcriptional program. The Integrator complex also exemplifies how coregulator complexes can be regulated to achieve gene-specific effects.
transcription coregulator binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HSF1 | Prostate cancer progression | Knockout or point mutation in prostate cancer cell lines |
| DBC1 | Prostate cancer metastasis | Overexpression or knockout in prostate cancer models |
| NCOA1 | Breast cancer, endocrine resistance | Knockout in breast cancer cell lines |
| NCOR1 | Endocrine resistance, leukemia | Point mutation or knockout in leukemia models |
| CREBBP | Rubinstein-Taybi syndrome | Knock-in of patient mutations in cell lines |
Cancer
Dysregulated transcription coregulator binding is a hallmark of many cancers. In prostate cancer, the HSF1-DBC1 axis activates a metastatic transcriptional program, highlighting how coregulator interactions can promote tumor progression. Nuclear receptor coregulators, such as NCOA1 and NCOR1, are implicated in hormone-dependent cancers, where their altered binding affinities contribute to endocrine resistance. Targeting coregulator interactions is a promising therapeutic strategy.
Developmental disorders
Mutations in genes encoding coregulators or their binding partners can cause developmental disorders. For example, mutations in CREBBP, which encodes a coactivator with acetyltransferase activity, are associated with Rubinstein-Taybi syndrome. This underscores the importance of coregulator binding in normal development.
Metabolic and inflammatory diseases
Coregulator binding is also involved in metabolic and inflammatory diseases. Nuclear receptor coregulators mediate responses to hormones and metabolic signals, and their dysfunction can contribute to metabolic syndrome. Atypical coregulators like Zincore may play roles in zinc finger transcription factor networks relevant to inflammation.
From transcription coregulator binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a coregulator affect transcription factor binding? | Knockout cell lines using CRISPR |
| Does a specific point mutation in a coregulator alter its interaction with transcription factors? | Point mutation knock-in cell lines |
| Can a tagged coregulator be used to map interactomes? | Tagged knock-in cell lines |
| Does overexpression of a coregulator drive oncogenic transcription? | Overexpression cell models |
| Which genes are regulated by a coregulator complex? | CRISPR library screening with RNA-seq readout |
| What is the genome-wide binding profile of a coregulator? | ChIP-seq in knockout and wild-type cells |
How to Study the transcription coregulator binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| AP-MS | Protein-protein interactions | Identifying coregulator complexes |
| RNA-seq | Gene expression changes | Assessing transcriptional impact of coregulator perturbation |
| ChIP-seq | Genome-wide binding sites | Mapping transcription factor and coregulator recruitment |
| Cryo-EM | Three-dimensional structures | Visualizing coregulator-transcription factor complexes |
| CRISPR screening | Gene essentiality and function | Discovering regulators of coregulator binding |
| Co-immunoprecipitation | Binary protein interactions | Validating coregulator binding partners |
| Reporter assays | Transcriptional activity | Measuring coregulator effects on specific promoters |
Proteomics and interactomics
Affinity purification coupled with mass spectrometry (AP-MS) is widely used to identify proteins that bind to transcription coregulators. By tagging a coregulator and expressing it in cells, researchers can isolate its complexes and identify interacting partners. This approach has been used to integrate coregulator complexes with DNA-binding factor interactomes.
Transcriptomics
RNA sequencing (RNA-seq) is used to measure changes in gene expression upon perturbation of coregulator binding. For example, knockout of a coregulator followed by RNA-seq can reveal the genes whose transcription depends on that coregulator. This method is essential for linking coregulator binding to specific transcriptional programs.
Genomic binding assays
Chromatin immunoprecipitation followed by sequencing (ChIP-seq) is used to map the genome-wide binding sites of transcription factors and coregulators. This technique can determine whether loss of a coregulator affects the recruitment of transcription factors to chromatin. It is a key method for studying transcription coregulator binding in a chromatin context.
Structural biology
X-ray crystallography and cryo-electron microscopy (cryo-EM) provide atomic-level insights into how coregulators bind to transcription factors. Molecular models of bidirectional promoter regulation have been developed using structural data. These methods reveal the interfaces and conformational changes that underlie coregulator binding.
How CRISPR Can Be Used to Study GO:0001221 transcription coregulator binding
Knockout
CRISPR knockout is used to delete genes encoding coregulators or their binding partners to study loss-of-function phenotypes. For example, knocking out HSF1 or DBC1 in prostate cancer cells can reveal their roles in metastatic transcriptional programs. Knockout models are essential for determining whether a coregulator is required for specific gene expression programs.
Point Mutation
CRISPR point mutation (base editing or prime editing) allows the introduction of specific amino acid changes in coregulators to dissect their binding interfaces. This is particularly useful for studying how mutations in coregulators affect their interactions with transcription factors, as seen in nuclear receptor coregulators.
Knock-in
Knock-in of tagged coregulators (e.g., GFP or HA tags) enables endogenous expression and interaction studies. Tagged knock-in cell lines can be used for AP-MS and ChIP-seq to map coregulator interactions and binding sites under physiological conditions.
Overexpression
Overexpression of coregulators using CRISPR activation (CRISPRa) or lentiviral vectors can model gain-of-function states observed in cancer. For instance, overexpression of DBC1 may enhance HSF1-driven transcription in prostate cancer. Overexpression models help identify oncogenic transcriptional programs driven by coregulator abundance.
How EDITGENE Supports transcription coregulator binding Research
Researchers studying transcription coregulator binding-related genes often need to determine whether a candidate gene is causally involved in a specific transcriptional program or disease phenotype. This requires precise genetic models that can knockout, mutate, tag, or overexpress the gene of interest in relevant cell types.
Contact EDITGENE today to design your custom CRISPR model for transcription coregulator binding research.
Frequently Asked Questions About transcription coregulator binding
What is transcription coregulator binding?
Transcription coregulator binding is the molecular function of binding to a transcription coregulator, a protein that regulates transcription through protein-protein interactions with transcription factors and other regulatory proteins, without binding DNA directly.
What is the GO ID for transcription coregulator binding?
The Gene Ontology ID for transcription coregulator binding is GO:0001221.
What genes are involved in transcription coregulator binding?
Genes encoding coregulators and their binding partners include NCOA1, NCOA2, NCOR1, NCOR2, EP300, CREBBP, MED1, Zincore, HSF1, DBC1, and many others.
How do coregulators regulate transcription?
Coregulators mediate protein-protein interactions between sequence-specific transcription factors and the basal transcription machinery, thereby activating or repressing transcription.
What diseases are associated with transcription coregulator binding?
Dysregulated coregulator binding is associated with cancer, developmental disorders, and metabolic diseases.
What methods are used to study transcription coregulator binding?
Common methods include AP-MS, RNA-seq, ChIP-seq, cryo-EM, and CRISPR screening.
Can CRISPR be used to study transcription coregulator binding?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect coregulator function.
What is an example of an atypical coregulator?
Zincore is an atypical coregulator that binds zinc finger transcription factors to control gene expression.
How is transcription coregulator binding regulated?
It is regulated by post-translational modifications, signaling pathways, and the availability of coregulators.
Why is transcription coregulator binding important for drug discovery?
Because coregulator interactions are often dysregulated in disease, they represent potential targets for therapeutic intervention.
Conclusion
Transcription coregulator binding (GO:0001221) is a fundamental molecular function that governs how transcription factors communicate with the basal transcription machinery. Its role in integrating signaling pathways and shaping gene expression programs makes it a key area of research in development, cancer, and metabolic diseases. Advances in CRISPR-based models and interactomics are providing unprecedented insights into the mechanisms and disease relevance of coregulator binding. Continued investigation of this function will likely yield new therapeutic strategies targeting transcriptional networks.
References
- 1. Velthuijs N et al.. 2021. Integration of transcription coregulator complexes with sequence-specific DNA-binding factor interactomes.. Biochim Biophys Acta Gene Regul Mech 1864(10):194749 PMID: 34425241
- 2. Bianchi D et al.. 2025. Zincore, an atypical coregulator, binds zinc finger transcription factors to control gene expression.. Science 389(6755):eadv2861 PMID: 40608935
- 3. Wiechens E et al.. 2025. Gene regulation by convergent promoters.. Nat Genet 57(1):206-217 PMID: 39779959
- 4. Sabath K et al.. 2024. Basis of gene-specific transcription regulation by the Integrator complex.. Mol Cell 84(13):2525-2541.e12 PMID: 38906142
- 5. Nemsick S et al.. 2024. Molecular models of bidirectional promoter regulation.. Curr Opin Struct Biol 87:102865 PMID: 38905929
- 6. Wei LN. 2003. Retinoid receptors and their coregulators.. Annu Rev Pharmacol Toxicol 43:47-72 PMID: 12142470
- 7. Gurevich I et al.. 2007. Corepressors of agonist-bound nuclear receptors.. Toxicol Appl Pharmacol 223(3):288-98 PMID: 17628626
- 8. Moon SJ et al.. 2025. HSF1-DBC1 axis drives prostate cancer progression by activating a metastatic transcriptional program.. Exp Mol Med 57(10):2277-2291 PMID: 41028522
